Dr. Peter Kecskemethy

Dr. Peter Kecskemethy is a serial entrepreneur and the CEO and Co-founder of Kheiron Medical, an AI cancer diagnostics company based in London.

Kheiron’s mission is to make cancer a routinely manageable disease, with a current focus on breast screening. In 2023, Kheiron’s groundbreaking work and patient impact were featured on the front cover of The New York Times. Prior to Kheiron, Peter founded two tech start-ups and was the tech lead for two others. He is a computer scientist, and did his Ph.D and post-doctoral research at the University of Oxford in high performance computing and computational statistics for population genetics.

European Innovations in MedTech: Driving Change, Saving Lives

March 10   |   2.30PM CT

Participate in this engaging discussion about the groundbreaking European technologies that are disrupting healthcare – tools that can help doctors achieve better outcomes for patients and their families.

Read more

The EU@SXSW panelists provided their biographies and bear responsibility for their content and wording.




Plan Your Visit

Funded by the EU


The European Union (EU) is represented in the United States by its Delegation in Washington, D.C., which works in close coordination with the Embassies of the 27 EU Member States.